Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

Alopecia areata is more common in women, often appears as patchy hair loss, and is usually treated with steroid injections and minoxidil.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Alopecia patients had similar element levels to normal people, except for differences in copper and low selenium.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Serenoa repens extract in topical products improves hair growth and appearance in male pattern baldness with mild side-effects.

A new microneedle patch effectively and safely treats alopecia areata.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

The document's conclusion cannot be determined from the provided text.

Alopecia areata in Spain has a significant impact with unmet treatment needs and high costs.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

Use oral or enteral nutrition when possible and reserve IV trace elements for those who truly need them.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

The early Iron Age settlement at Raposal shows diverse cultural influences and challenges previous ideas about settlement types in the Ebro Valley.

Dermoscopy is a useful tool for diagnosing female pattern hair loss.

EF and PXE not closely related.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

A new tool simplifies alopecia areata severity scoring but needs validation.